quick-dive-tauchgang-shutterstock-343349687-32zu9-1920x540

Quick Dive: Environmental stressors and cardiovascular health

In our "Quick Dive" series, the authors of publications from medical societies summarise the most important information and results of the respective publication. This time we dive into:

Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World

A statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation

20 January 2026 | Written by: Thomas Münzel, Thomas Lüscher, Christopher M. Kramer, Keith Churchwell, Amam Mbakwem, Sanjay Rajagopalan

By:

Martin Nölke

HERZMEDIZIN editorial team

 

2026-02-18

Image source (image above): vovan / Shutterstock.com (edited)

5 questions for the author

Dr. Christopher M. Kramer, University of Virginia, Charlottesville, USA

What is the reason for and aim of the publication?

 

The reason for the publication is to raise awareness of the role of Environmental Risk Factors (ERFs) in increasing the incidence of Non-Communicable Diseases (NCDs) which account for 70% of mortality world-wide.

 

What are the most important take-home messages?

 

  1. ERFs play an increasingly important role in the incidence of NCDs.
  2. ERFs include air pollution, water pollution, soil pollution, noise pollution, chemical pollution, plastic pollution, artificial light, and global warming leading to climate change.
  3. Recognition of the problem and political will are necessary to reduce the presence of ERFs, thereby reducing environmental stressors and improving cardiovascular health.
Environmental stressors and cardiovascular health
© Münzel T. et al. European Heart Journal.

Central Illustration. Environmental stressors and cardiovascular health multiple environmental exposures, including noise and light pollution, air pollution, water and soil contamination, chemical pollution, and climate change, contribute to cardiovascular disease (CVD) through shared and interacting pathways involving oxidative stress, inflammation, autonomic imbalance, and endothelial dysfunction. The interplay among these stressors amplifies overall cardiovascular risk and underscores the need for integrated exposome-based prevention strategies.

What are challenges in practical implementation – and possible solutions?

 

Lack of awareness of the scope of the problem is the major challenge to implementations of the changes necessary to reduce ERFs. Education of politicians, healthcare workers and the general public are necessary to overcome this lack of awareness.

 

 

Which issues still need to be tackled, that are not yet addressed by the paper?

 

The economic pressures against tackling the problem of ERFs was not addressed by the paper. These present a major hurdle for those interested in policy change.

 

What further developments on the topic are emerging?

 

New ERFs that impact on the incidence of NCDs are constantly being identified.

Continue to the publication:

Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World

Münzel T, Lüscher T, Kramer C. et al. Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation. JACC. https://doi.org/10.1016/j.jacc.2026.01.015

 

About the author

Dr. Christopher M. Kramer

Dr. Christopher M. Kramer is Chief of the Cardiovascular Division at the Department of Medicine, University of Virginia. His work focuses on cardiovascular magnetic resonance to the cardiovascular System – especially in areas such as left ventricular remodeling and myocardial viability, atherosclerotic plaque imaging or peripheral arterial disease. Presently, he is the President of the American College of Cardiology (ACC).

Dr. Christopher M. Kramer

ESC Document types

Document types published by the ESC, Associations, Councils, Working Groups, and ESC Committees (according to the ESC Scientific Documents Policy):

ESC Clinical Practice Guidelines present the official ESC position on key topics in cardiovascular medicine. They are based on the assessment of published evidence and consensus by an independent group of experts. The documents include standardized, graded recommendations for clinical practice and indicate the level of supporting evidence.

ESC Pocket Guidelines provide a compact, practice-oriented summary of the full guideline, including all recommendation classes and levels of evidence.

Clinical Consensus Statements provide guidance for clinical management on topics not covered or not covered in sufficient detail in existing or upcoming ESC Clinical Practice Guidelines by evaluating scientific evidence or exploring expert consensus in a structured way. 

Scientific Consensus Statements interpret scientific evidence and provide a summary position on the topic without specific advice for clinical practice.

Statements outline and convey the organisation’s position or policy on non-medical issues such as education, advocacy and ethical considerations.

ESC Quality Indicators enable healthcare providers to develop valid and feasible metrics to measure and improve the quality of cardiovascular care and describe, in a specific clinical situation, aspects of the process of care that are recommended (or not recommended) to be performed.

Related news

Publications from medical societies – this time: ESC consensus on standardized atrial regions for 3D mapping and imaging. By Dr. T. F. Althoff.

Publications from Medical Societies – this time: ESC statement on non-amyloid specific treatment for transthyretin cardiac amyloidosis. By Dr. P. García-Pavia.

Publications from Medical Societies – this time: the ESC statement on reframing outcomes for physical activity beyond mortality. By PD Dr. Dr. M. Bahls.